DOI: 10.1161/circ.148.suppl_1.11451 ISSN: 0009-7322

Abstract 11451: Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease

Maneesh Sud, Atul Sivaswamy, Peter Austin, Robert J Hester, David Naimark, Michael E Farkouh, Douglas Lee, Idan Roifman, George Thanassoulis, Karen Tu, Jacob A Udell, Harindra C Wijeysundera, Dennis T Ko
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Background: The use of atherosclerotic cardiovascular disease (ASCVD) prediction models is suboptimal in clinical practice partly because of the need to gather history, physical and laboratory measures. Automation of risk assessment using only demographic and laboratory results may overcome this limitation. Our objective was to develop and validate sex-specific prediction models for ASCVD using age and routine laboratory tests and compare their performance to the Pooled Cohort Equations (PCEs).

Methods: Models were derived and internally validated in Ontario residents aged 40 to 75 years without cardiovascular disease who had outpatient laboratory testing from April 1, 2009 to December 31, 2015. Estimates of the 5-year risk of ASCVD (myocardial infarction, stroke, death from ischemic heart or cerebrovascular disease) were obtained from Fine-Gray models that included age, total cholesterol, high-density lipoprotein cholesterol, triglycerides, hemoglobin, mean corpuscular volume, platelets, leukocytes, estimated glomerular filtration rate, and glucose as predictors. Models were externally validated in a primary care cohort assembled from electronic medical record data and compared with the PCEs.

Results: Sex-specific models were developed and internally validated in 2,160,497 women and 1,833,147 men. They were well calibrated with less than 2% relative difference between mean predicted and observed risk. The C-statistic was 0.77 in women and 0.72 in men. External validation in 31,697 primary care patients demonstrated less than 15% relative and less than 0.3% absolute difference in mean predicted and observed risks ( Figure ). The C-statistics for the lab models were 0.72 for both sexes and were not significantly different from the C-statistics for the PCEs in women (p=0.18 for difference) or men (p=0.35).

Conclusions: We developed and validated the CANHEART Lab Models that predict ASCVD with similar accuracy to more complex models such as the PCEs.

More from our Archive